Several studies have documented an increased expression of NLRP3 inflammasome components in renal parenchymal cells in experimental and human DKD and hence speculated on a role of IL-1β in CKD progression (18, 43–46). The gene discussed is IL1B; the disease is diabetic kidney disease.